Item 2. Unregistered Sales of Equity Securities
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
Unregistered
Sales
On
May 16, 2019, our Sponsor purchased an aggregate of 8,625,000 Founder Shares for $25,000, or approximately $0.003 per share. The
Founder Shares will automatically convert into shares of our Class A common stock at the time of our initial business combination.
On July 25, 2019, our Sponsor transferred an aggregate of 80,000 Founder Shares to two of our independent directors at their original
purchase price. In September 2019, our Sponsor forfeited an aggregate of 772,059 Founder Shares. On July 31, 2020, our Sponsor
transferred an aggregate of 40,000 Founder Shares to our third independent director at their original purchase price. The Founder
Shares were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2)
of the Securities Act.
Simultaneously
with the consummation of our Public Offering, our Sponsor purchased from the Company an aggregate of 5,333,333 Private Placement
Warrants at a price of $1.50 per Private Placement Warrant (for a purchase price of approximately $8.0 million). In addition,
simultaneously with the closing of the sale of the Over-allotment Units, we consummated the sale of an additional 188,235 Private
Placement Warrants in a private placement to our Sponsor, generating gross proceeds of approximately $282,000. Each Private Placement
Warrant entitles the holder thereof to purchase one share of our Class A common stock at an exercise price of $11.50 per share.
The sales of the Private Placement Warrants were made pursuant to the exemption from registration contained in Section 4(a)(2)
of the Securities Act.
25
Use
of Proceeds
On
July 30, 2019, we consummated the Public Offering of 30,000,000 Units. The Units were sold at a price of $10.00 per Unit, generating
gross proceeds of $300.0 million. Certain of our officers and directors purchased 200,000 of the 30,000,000 Units sold in the
Public Offering for an aggregate purchase price of $2.0 million. The underwriters were granted a 45-day option from the date of
the final prospectus relating to the Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if
any, at $10.00 per Unit, less underwriting discounts and commissions. On September 4, 2019, the underwriters partially exercised
the over-allotment option and, on September 6, 2019, the underwriters purchased 1,411,763 of the Over-allotment Units, generating
gross proceeds of approximately $14.1 million. The remaining over-allotment option subsequently expired.
On
July 30, 2019, simultaneously with the closing of the Public Offering, we completed the private sale of 5,333,333 Private Placement
Warrants at a purchase price of $1.50 per Private Placement Warrant to our Sponsor, generating gross proceeds of approximately
$8.0 million. Simultaneously with the closing of the sale of the Over-allotment Units, we completed the private sale of an additional
188,235 Private Placement Warrants at a purchase price of $1.50 per Private Placement Warrant to our Sponsor, generating gross
proceeds of approximately $282,000.
Goldman
Sachs & Co. LLC, Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC, RBC Capital Markets, LLC and Tudor, Pickering,
Holt & Co. Securities, Inc. served as underwriters for the Public Offering. The securities sold in the Public Offering were
registered under the Securities Act on a registration statement on Form S-1 (File No. 333-232501) (the “Registration Statement”).
The SEC declared the Registration Statement effective on July 25, 2019.
From
May 10, 2019 (inception) through December 31, 2019, we incurred approximately $17.7 million for costs and expenses related to
the Public Offering, including an up-front fee of approximately $6.24 million in underwriting discounts and commissions and approximately
$10.92 million in deferred underwriting discounts and commissions, which amount will be payable upon consummation of our initial
business combination. Prior to the closing of the Public Offering, our Sponsor loaned us approximately $251,000 under a promissory
note (the “Note”). We repaid this Note to our Sponsor on August 12, 2019. There has been no material change in the
planned use of proceeds from the Public Offering as described in our final prospectus filed with the SEC on July 29, 2019.
After
deducting the underwriting discounts and commissions (excluding the deferred portion of approximately $10.92 million, which amount
will be payable upon consummation of our initial business combination) and offering expenses, the total net proceeds from the
Public Offering and the sale of the Private Placement Warrants were approximately $315.1 million, of which approximately $314.1
million (or $10.00 per share sold in the Public Offering) was placed in the Trust Account.
Item 3.
Defaults Upon Senior Securities
None.
Item 4.
Mine Safety Disclosures
Not
applicable.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.